Association between KRAS rs61764370 and triple-negative breast cancer-a false positive? - Authors' reply

The Lancet Oncology

Volumn 12, Issue 8, 2011, Pages 724-

  Weidhaas, Joanne ^a   Slack, Frank ^b   Miller, Nicola ^c   Harris, Lyndsay ^a   Tuck, David ^a   Zhu, Yong ^b   Zelterman, Daniel ^b   Kerin, Michael ^c   Paranjape, Trupti ^a   Heneghan, Helen ^c   Lindner, Robert ^d   Keane, Florence ^a   Dorairaj, Jemima ^c   Geyda, Kimberly ^a   Pelletier, Cory ^a   Nallur, Sunitha ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

FALSE NEGATIVE RESULT; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; KRAS GENE; LETTER; PREMENOPAUSE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRIPLE NEGATIVE BREAST CANCER;

EID: 79960854314     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70163-2     Document Type: Letter

References (1)

1. Paranjape T, Heneghan H, Lindner R, et al. A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis. Lancet Oncol 2011, 12:377-386.